Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
Investing Profile

Nanna Luneborg

InvestorVC
General Partner at Forbion
Forbion General Partner
$100K - $5.0M
$1.5M
12
CompanyStageDateRound SizeTotal Raised
Noema Pharma
Series BDec 2024$31M
Series BMar 2023$110M
$290M
Co-investors: Felice Verduyn - van Weegen (EQT Life Sciences), Antoine Papiernik Papiernik (Soffinova Partners)
Capstan Therapeutics
Series BMar 2024$180M
$280M
Co-investors: Michael Baran (Pfizer Venture Investments)
Inversago Pharma
Series COct 2022$69M
$110M
Co-investors: Ed Mathers (New Enterprise Associates (NEA)), Elizabeth Douville (Amorchem), Marco Boorsma (Forbion)
F2G
Private EquityAug 2022$70M
$160M
Co-investors: Anja Konig (Novartis Venture Fund), Maha Katabi (Sofinnova Investments), Joseph Anderson (Soffinova Partners), Raj Parekh (Advent Life Sciences)
Numab
Series CMay 2021$110M
$110M
Lava Therapeutics
Series CSep 2020$83M
$100M
Co-investors: Guido Magni (Versant Ventures), Joël Jean-Mairet (Ysios Capital), Laia Crespo (Sanofi Ventures)
NodThera
Series BJun 2020$55M
$95M
Co-investors: Scott Rocklage (5am Ventures), Alexander Pasteur (F-Prime Capital Partners), Henrijette Richter (Soffinova Partners)
NBE-Therapeutics
Series BJun 2018$20M
$20M